Table 2.
Spearman r (p value) | Gender | Age | p-mTOR | p-S6K1 | Tumor differentiation | Tumor size | TNM stage |
---|---|---|---|---|---|---|---|
Gender (female versus male) | −0.03 (0.750) | −0.07 (0.413) | −0.18 (0.037)∗ | 0.14 (0.116) | 0.06 (0.517) | 0.08 (0.357) | |
Age (≥60 years versus <60 years) | −0.03 (0.750) | −0.14 (0.117) | −0.12 (0.175) | −0.02 (0.818) | −0.07 (0.442) | −0.06 (0.503) | |
p-mTOR (low versus high) | −0.07 (0.413) | −0.14 (0.117) | 0.24 (0.006)∗∗ | −0.02 (0.803) | −0.01 (0.926) | 0.01 (0.937) | |
p-S6K1 (low versus high) | −0.18 (0.037)∗ | −0.12 (0.175) | 0.24 (0.006)∗∗ | −0.04 (0.675) | 0.06 (0.499) | 0.02 (0.867) | |
Tumor differentiation (well versus moderate, poor) | 0.14 (0.116) | −0.02 (0.818) | −0.02 (0.803) | −0.04 (0.675) | 0.17 (0.047)∗ | 0.16 (0.066) | |
Tumor size (≥4 cm versus <4 cm) | 0.06 (0.517) | −0.07 (0.442) | −0.01 (0.926) | 0.06 (0.499) | 0.17 (0.047)∗ | 0.37 (< 0.001)∗∗∗ | |
TNM stage (0–II versus III–IV) | 0.08 (0.357) | −0.06 (0.503) | 0.01 (0.937) | 0.02 (0.867) | 0.16 (0.066) | 0.37 (< 0.001)∗∗∗ |